Gin Hwa Biotech Incorporation (TPEX:7806)

Taiwan · Delayed Price · Currency is TWD

50.00

-1.70 (-3.29%)

At close: Nov 6, 2026

Market Cap	1.61B +9.5%
Revenue (ttm)	535.88M +5.4%
Net Income	55.70M -27.1%
EPS	1.98 -35.8%
Shares Out	32.25M
PE Ratio	25.21
Forward PE	n/a
Dividend	0.95 (1.91%)
Ex-Dividend Date	Jul 27, 2026

Volume	99,454
Open	46.70
Previous Close	51.70
Day's Range	46.70 - 50.90
52-Week Range	49.50 - 77.62
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About TPEX:7806

Gin Hwa Biotech Incorporation manufactures and sells health supplements in Taiwan. The company offers nutritional supplements in various dosage forms, including soft gel encapsulations, tablets, capsules, liquids/ointments, powders, drop extracts, ready-to-drink, liquid sachets, pop rocks, tea bags, powder blends, ampoules, jellies, and other formats. Its products contain neuroboost, myorenew, dermaessence, cranbliss, and glycobalance ingredients. Gin Hwa Biotech Incorporation was founded in 2019 and is based in Kaohsiung, Taiwan. [Read more]

Industry Pharmaceutical Preparations

Founded 2019

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 7806

Full Company Profile

Financial Performance

In 2025, TPEX:7806's revenue was 538.65 million, an increase of 23.80% compared to the previous year's 435.08 million. Earnings were 75.33 million, an increase of 12.85%.

Financial Statements